loadpatents
name:-0.05124306678772
name:-0.029902219772339
name:-0.014971017837524
YUN; Chae Ok Patent Filings

YUN; Chae Ok

Patent Applications and Registrations

Patent applications and USPTO patent grants for YUN; Chae Ok.The latest application filed is for "antitumor immunity enhancing composition containing adenovirus simultaneously expressing il-12 and shvegf".

Company Profile
14.38.46
  • YUN; Chae Ok - Seoul KR
  • YUN; Chae Ok - Seocho-Gu Seoul
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Antitumor Immunity Enhancing Composition Containing Adenovirus Simultaneously Expressing Il-12 And Shvegf
App 20220233718 - YUN; Chae Ok ;   et al.
2022-07-28
Anticancer composition comprising tumor-specific oncolytic adenovirus and immune checkpoint inhibitor
Grant 11,364,272 - Yun , et al. June 21, 2
2022-06-21
Ph-sensitive And Bioreducible Polymer-virus Complex For Cancer Treatment
App 20220090025 - YUN; Chae Ok ;   et al.
2022-03-24
Adenovirus complex for gene delivery and gene iherapy
Grant 11,235,072 - Yun , et al. February 1, 2
2022-02-01
Anti-tumor Composition
App 20210386806 - YUN; Chae Ok ;   et al.
2021-12-16
Ph-sensitive and bioreducible polymer-virus complex for cancer treatment
Grant 11,174,465 - Yun , et al. November 16, 2
2021-11-16
Virus-PCION complex having enhanced antitumor effect by using electromagnetic field
Grant 11,000,590 - Yun , et al. May 11, 2
2021-05-11
Recombinant Adenoviruses And Stem Cells Comprising Same
App 20210069253 - YUN; Chae Ok ;   et al.
2021-03-11
Cell Sheet For Gene Delivery
App 20210054332 - YUN; Chae Ok ;   et al.
2021-02-25
Composition for preventing or treating keloid or hypertrophic scars
Grant 10,864,283 - Yun , et al. December 15, 2
2020-12-15
Complex of adenovirus and PAMAM-PEG-Erbitux, and use thereof
Grant 10,849,987 - Yun , et al. December 1, 2
2020-12-01
Intranasal Pharmaceutical Composition Comprising Anticancer Drugcontaining Nanoparticles For Treating Brain Diseases
App 20200323811 - LEE; Sang-Kyung ;   et al.
2020-10-15
Composition for intracellular delivery containing adenovirus protein VI-derived peptide and anticancer pharmaceutical composition containing same
Grant 10,722,587 - Yun
2020-07-28
Peptide having anticancer activity, and pharmaceutical composition and dietary supplement composition for preventing and treating cancer, both of which contain same as active ingredient
Grant 10,611,797 - Kim , et al.
2020-04-07
Anticancer Composition Comprising Tumor-specific Oncolytic Adenovirus And Immune Checkpoint Inhibitor
App 20190388488 - YUN; Chae Ok ;   et al.
2019-12-26
Anticancer Composition Comprising Recombinant Adenovirus Expressing Degradation Factor For Extracellular Matrix
App 20190358277 - YUN; Chae Ok ;   et al.
2019-11-28
Gene Delivery System Containing Relaxin Gene And Pharmaceutical Composition Using Relaxin
App 20190323035 - YUN; Chae-Ok ;   et al.
2019-10-24
Virus-pcion Complex Having Enhanced Antitumor Effect By Using Electromagnetic Field
App 20190298831 - YUN; Chae Ok ;   et al.
2019-10-03
Virus-PCION complex having enhanced antitumor effect by using electromagnetic field
Grant 10,357,564 - Yun , et al. July 23, 2
2019-07-23
Complex Of Adenovirus And Pamam-peg-erbitux, And Use Thereof
App 20190134218 - YUN; Chae Ok ;   et al.
2019-05-09
Antitumor Immunity Enhancing Composition Containing Adenovirus Simultaneously Expressing Il-12 And Shvegf
App 20180369417 - YUN; Chae Ok ;   et al.
2018-12-27
Composition For Preventing Or Treating Keloid Or Hypertrophic Scars
App 20180326094 - YUN; Chae Ok ;   et al.
2018-11-15
Adenovirus Complex For Gene Delivery And Gene Therapy
App 20180296701 - YUN; Chae Ok ;   et al.
2018-10-18
Conditionally replicating adenovirus to express REIC gene
Grant 10,071,126 - Kumon , et al. September 11, 2
2018-09-11
Composition For Intracellular Delivery Containing Adenovirus Protein Vi-derived Peptide And Anticancer Pharmaceutical Composition Containing Same
App 20180243430 - YUN; Chae Ok
2018-08-30
Decorin gene delivery system and cancer treatment
Grant 10,046,067 - Yun , et al. August 14, 2
2018-08-14
PPSA and Pspa polymer-virus complex and pharmaceutical compositions comprising the same
Grant 9,974,818 - Yun , et al. May 22, 2
2018-05-22
Peptide Having Anticancer Activity, And Pharmaceutical Composition And Dietary Supplement Composition For Preventing And Treating Cancer, Both Of Which Contain Same As Active Ingredient
App 20180086788 - KIM; Chul Geun ;   et al.
2018-03-29
Anti-cancer compositions containing Wnt decoy receptor
Grant 9,920,099 - Yun , et al. March 20, 2
2018-03-20
Recombinant adenoviruses capable of regulating angiogenesis
Grant 9,850,500 - Yun , et al. December 26, 2
2017-12-26
Anti-cancer Compositions Containing Wnt Decoy Receptor
App 20170275340 - YUN; Chae Ok ;   et al.
2017-09-28
Virus-pcion Complex Having Enhanced Antitumor Effect By Using Electromagnetic Field
App 20170258906 - YUN; Chae Ok ;   et al.
2017-09-14
Conditionally Replicating Adenovirus To Express Reic Gene
App 20170202892 - KUMON; Hiromi ;   et al.
2017-07-20
Gene delivery system having enhanced tumor-specific expression, and recombinant gene expression regulating sequence
Grant 9,689,000 - Yun , et al. June 27, 2
2017-06-27
Anti-cancer compositions containing WNT decoy receptor
Grant 9,657,069 - Yun , et al. May 23, 2
2017-05-23
Ph-sensitive And Bioreducible Polymer-virus Complex For Cancer Treatment
App 20170119890 - YUN; Chae Ok ;   et al.
2017-05-04
Decorin Gene Delivery System And Cancer Treatment
App 20170080106 - YUN; Chae-Ok ;   et al.
2017-03-23
Ppsa And Pspa Polymer-virus Complex And Pharmaceutical Compositions Comprising The Same
App 20170080036 - YUN; Chae Ok ;   et al.
2017-03-23
Decorin gene delivery system and cancer treatment
Grant 9,468,690 - Yun , et al. October 18, 2
2016-10-18
Human monoclonal antibody neutralizing vascular endothelial growth factor receptor and use thereof
Grant 9,249,219 - Yoo , et al. February 2, 2
2016-02-02
Human monoclonal antibody neutralizing vascular endothelial growth factor receptor and use thereof
Grant 9,249,220 - Yoo , et al. February 2, 2
2016-02-02
Gene Delivery System Containing Relaxin Gene And Pharmaceutical Composition Using Relaxin
App 20150368669 - YUN; Chae-Ok ;   et al.
2015-12-24
Pharmaceutical composition for treating cancer
Grant 9,217,149 - Won , et al. December 22, 2
2015-12-22
Recombinant adenovirus with enhanced therapeutic effect and pharmaceutical composition comprising said recombinant adenovirus
Grant 9,175,309 - Yun , et al. November 3, 2
2015-11-03
Human monoclonal antibody neutralizing vascular endothelial growth factor receptor and use thereof
Grant 9,150,650 - Yoo , et al. October 6, 2
2015-10-06
Tumor specific promoter and oncolytic virus vector comprising the same
Grant 9,018,182 - Koh , et al. April 28, 2
2015-04-28
Pharmaceutical Composition For Treating Cancer
App 20140371300 - Won; Misun ;   et al.
2014-12-18
Anti-cancer Compositions Containing Wnt Decoy Receptor
App 20140315825 - Yun; Chae Ok ;   et al.
2014-10-23
Pharmaceutical composition for treating cancer
Grant 8,846,630 - Won , et al. September 30, 2
2014-09-30
Human Monoclonal Antibody Neutralizing Vascular Endothelial Growth Factor Receptor And Use Thereof
App 20140288274 - Yoo; Jin-San ;   et al.
2014-09-25
Human Monoclonal Antibody Neutralizing Vascular Endothelial Growth Factor Receptor And Use Thereof
App 20140275488 - YOO; Jin-San ;   et al.
2014-09-18
Gene Delivery System Having Enhanced Tumor-specific Expression, And Recombinant Gene Expression Regulating Sequence
App 20130323206 - Yun; Chae Ok ;   et al.
2013-12-05
Use of FLJ25416 gene
Grant 8,486,905 - Won , et al. July 16, 2
2013-07-16
Recombinant Adenovirus Having Anti-Angiogenesis Activity
App 20130101557 - Yun; Chae Ok
2013-04-25
Tumor-specific Promoter And Oncolytic Virus Vector Comprising The Same
App 20130065952 - Koh; Daekyung ;   et al.
2013-03-14
Pharmaceutical Composition For Treating Cancer
App 20130028957 - Won; Misun ;   et al.
2013-01-31
Methods for effectively coexpressing IL-12 and IL-23
Grant 8,298,790 - Yun October 30, 2
2012-10-30
Cell Sensor, And Monitoring Method Using Same For The Real-Time Monitoring Of Cell Capacitance
App 20120064513 - Yoo; Kyung Hwa ;   et al.
2012-03-15
Modified tert promoter with enhanced tumor-specificity and strength and recombinant vector comprising the same
Grant 8,067,567 - Yun , et al. November 29, 2
2011-11-29
Method for stimulating angiogenesis using DKK2 and composition comprising the same
Grant 8,067,387 - Kwon , et al. November 29, 2
2011-11-29
Methods for Effectively Coexpressing IL-12 and IL-23
App 20110124048 - Yun; Chae-Ok
2011-05-26
Human Monoclonal Antibody Neutralizing Vascular Endothelial Growth Factor Receptor And Use Thereof
App 20110065176 - Yoo; Jin-San ;   et al.
2011-03-17
Novel Use Of Flj25416 Gene
App 20110008370 - Won; Misun ;   et al.
2011-01-13
Recombinant Adenoviruses Capable Of Regulating Angiogenesis
App 20100215621 - Yun; Chae-Ok ;   et al.
2010-08-26
Method For Stimulating Angiogenesis Using Dkk2 And Composition Comprising The Same
App 20090275509 - Kwon; Young-Guen ;   et al.
2009-11-05
Decorin Gene Delivery System And Cancer Treatment
App 20080132449 - Yun; Chae-Ok ;   et al.
2008-06-05
Gene Delivery System Containing Relaxin Gene And Pharmaceutical Composition Using Relaxin
App 20070202080 - Yun; Chae-Ok ;   et al.
2007-08-30
Modified tert promoter with enhanced tumor-specificity and strength and recombinant vector comprising the same
App 20070059287 - Yun; Chae-Ok ;   et al.
2007-03-15
Recombinant adenovirus with enhanced therapeutic effect and pharmaceutical composition comprising said recombinant adenovirus
App 20050002965 - Yun, Chae-Ok ;   et al.
2005-01-06

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed